Sub-dissociative-dose intranasal ketamine for moderate to severe pain in adult emergency department patients
MetadataShow full item record
Background: There are currently no studies assessing effectiveness of sub-dissociative intranasal (IN) ketamine as the initial analgesic for adult patients in the ED. Objective: The study aims to examine the effectiveness of sub-dissociative IN ketamine as a primary analgesic agent for adult patients in the ED. Method: This is a prospective, observational study of adult ED patients presenting with severe pain (=6 on 11-point scale at triage). IN ketamine dose was 0.7mg/kg, with secondary dose of 0.5mg/kg at 15min if pain did not improve. After 6 months, initial dose was increased to 1.0mg/kg with the same optional secondary dose. Primary outcomes: The primary outcomes are change in VAS rating at 30min; percentage of patients reporting clinically significant reduction in VAS (=20mm) at 30min; dose resulting in clinically significant pain reduction. Results: Of the 72 patients available for analysis, median age was 34.5 years and 64% were men. Median initial VAS rating was 76mm (interquartile range [IQR]: 65-82). Median total dose of IN ketamine for all patients was 0.98mg/kg (IQR: 0.75-1.15, range: 0.59-1.57). Median reduction in VAS rating at 30min was 24mm (IQR: 2-45). Forty (56%, 95% CI: 44.0-66.7) reported VAS reduction =20mm, these patients having had a total median ketamine dose of 0.94mg/kg (IQR: 0.72-1.04). Conclusion: IN ketamine, at a dose of about 1mg/kg, was an effective analgesic agent in 56% of study patients. The place of IN ketamine in analgesic guidelines for adults requires further investigation.
Showing items related by title, author, creator and subject.
The PICHFORK (Pain InCHildren Fentanyl OR Ketamine) trial comparing the efficacy of intranasal ketamine and fentanyl in the relief of moderate to severe pain in children with limb injuries: Study protocol for a randomized controlled trialGraudins, A.; Meek, R.; Egerton-Warburton, Diana; Seith, R.; Furness, T.; Chapman, Rose (2013)Background: The effectiveness of intranasal (IN) fentanyl as an analgesic for painful pediatric limb injuries in the Emergency Department (ED) has been reported previously. However, efficacy of IN ketamine in sub-dissociative ...
The PICHFORK (Pain in Children Fentanyl or Ketamine) Trial: A randomized controlled trial comparing intranasal ketamine and fentanyl for the relief of moderate to severe pain in children with limb injuriesGraudins, A.; Meek, R.; Egerton-Warburton, Diana; Oakley, E.; Seith, R. (2015)© 2014 American College of Emergency Physicians.Study objective We compare the analgesic effectiveness of intranasal fentanyl and ketamine in children. Methods This was a double-blind, randomized, controlled trial comparing ...
Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model ratsKadowaki, D.; Sumikawa, S.; Arimizu, K.; Taguchi, K.; Kitamura, K.; Ishitsuka, Y.; Narita, Y.; Irie, T.; Chuang, Victor; Maruyama, T.; Otagiri, M.; Hirata, S. (2012)Aims: Acetaminophen is a safe antipyretic and analgesic drug within the clinically recommended dosage range, but overdose can cause fatal liver and or kidney damage. Most of the nonsteroidal anti-inflammatory drugs (NSAIDs) ...